Proteomics

Dataset Information

0

Intact mass and middle-down analysis for mAbs


ABSTRACT: An integrated strategy has been developed to characterize Trastuzumab and Adalimumab structural heterogeneity, which has prominent advantages in fast sample preparation with minimal artifacts, and complementary information obtained from intact mass and middle-down analyses.

ORGANISM(S): Homo Sapiens

SUBMITTER: Jinlan Zhang  

PROVIDER: PXD021287 | iProX | Thu Sep 03 00:00:00 BST 2020

REPOSITORIES: iProX

Similar Datasets

2022-03-14 | PXD002535 | Pride
| 2410037 | ecrin-mdr-crc
| PRJNA954296 | ENA
2012-09-30 | E-GEOD-32207 | biostudies-arrayexpress
2020-11-02 | PXD017618 | Pride
2025-04-23 | GSE268496 | GEO
2025-02-26 | PXD054948 | Pride
2021-12-30 | PXD024643 | Pride
2024-11-20 | PXD041358 | Pride
| PRJNA780947 | ENA